Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach.

ABSTRACT:

SUBMITTER: Mandhair HK 

PROVIDER: S-EPMC10844068 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature